Reference number : 236-2012-2013-Q4-00192, amendment number : , agreement type : G, recipient legal name : TSANTRIZOS, Youla S, recipient country : CA, recipient province : QC, recipient city : Montreal, recipient postal code : H3A 2T5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 703950.0, agreement start date : 2013-04-01, agreement end date : 2018-03-31, description english : Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases., description french : Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2013-14 to 2017-18), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2013-14 à 2017-18), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada